Rethinking How ADHD Medications Work

Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental conditions diagnosed in both children and adults today. In the United States alone, millions of children are prescribed medication to help manage symptoms like inattention, impulsivity, and hyperactivity. Many adults rely on these same treatments to support focus and daily functioning.

For a lot of people, stimulant medications can be life-changing tools. But new research is prompting clinicians and scientists to take a closer look at how these medications are actually working in the brain.

What the new research is showing

A December 2025 study published in Cell, titled “Stimulant medications affect arousal and reward, not attention networks,” challenges a long-standing assumption in ADHD treatment.

For years, clinicians were taught that stimulant medications, such as Ritalin, work primarily by enhancing the brain’s “attention systems,” helping people have more voluntary control over where they focus. But this new research suggests something different.

Using large-scale brain imaging data from nearly 6,000 children in the Adolescent Brain Cognitive Development (ABCD) Study, along with follow-up experiments in adults, researchers found that stimulant medications do not primarily activate attention networks in the brain. Instead, they appear to influence two other key systems:

• Wakefulness (arousal) networks, which affect alertness and energy

• Reward systems, which influence motivation and how interesting or worthwhile a task feels

  
  

In other words, the improvement in focus many people experience may not come from directly “turning on” attention circuits, but rather from helping the brain feel more awake and more motivated to engage with tasks.

Additionally, the study found that stimulant medications could temporarily counteract some of the cognitive effects of sleep deprivation in children with ADHD, effectively masking the impact of poor sleep on attention and performance. However, this effect was not seen in neurotypical children.

This is an important distinction. While medication may help individuals function in the short term, it does not eliminate the underlying consequences of insufficient sleep. And as the researchers note, chronic sleep deprivation carries real long-term risks, especially for children and adolescents whose brains are still developing. The study even suggests that improving sleep may produce some of the same cognitive benefits attributed to stimulant medications.

Our Perspective

While this research raises important considerations, particularly around the role of sleep, it’s essential to interpret these findings within the broader understanding of ADHD.

Attention is not governed by a single area of the brain. Rather, it involves complex interactions across multiple regions, particularly within the fronto-parietal networks, which are consistently linked to attention and executive functioning. ADHD is not a simple, single-pathway condition, and its treatment cannot be reduced to one mechanism.

There is strong evidence that sleep quality and quantity play a critical role in overall cognitive functioning. Addressing sleep deprivation can absolutely improve focus, energy, and mental clarity. However, treating sleep issues alone is unlikely to fully resolve core ADHD symptoms.

Important Limitations to Consider

As with any emerging research, there are limitations worth noting:

• Arousal does not equal focus.

  While stimulant medications may increase alertness, individuals with ADHD may still struggle with distractibility. Increased arousal alone does not guarantee improved executive functioning.

• Reward system effects may not be sustained.

  Medications that enhance the brain’s reward response may be helpful in the short term, particularly when motivation is tied to anticipated outcomes. However, over time, desensitization can occur, reducing the long-term effectiveness of this mechanism.

A More Comprehensive View of ADHD

ADHD involves multiple interconnected brain systems, including:

• Mesolimbic pathways – linked to motivation and reward

• Mesocortical pathways – responsible for attention, working memory, and decision-making

• Nigrostriatal pathways – associated with movement and hyperactivity

Because ADHD affects several brain circuits, effective treatment often requires a multifaceted approach. While stimulant medications remain a valuable tool, there is an ongoing need for treatments that better target these systems without negatively impacting sleep or mood.

Moving Forward

This new research contributes to an evolving understanding of ADHD and highlights the importance of looking beyond a one-size-fits-all explanation. Sleep, neurobiology, and individualized treatment strategies all play a role in effective care.

As always, patients should consult with a qualified provider before making any changes to their treatment plan. ADHD is complex, and so is the path to managing it well.

Reach out to PPS today to make an appointment with a professional.

Contact Us